. . . . . . . . . . . . . . "a(CHEBI:rosiglitazone) -| sec(p(MGI:Retn))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Circulating resistin levels are decreased by the anti-diabetic drug rosiglitazone, and increased in diet-induced and genetic forms of obesity." . . "Selventa" . . . . "2014-07-03T14:29:54.286+02:00"^^ . . .